Mu Ye
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A noninvasive and highly efficient epigenetic predictive model for efficacy of the GOLP regimen in patients with intrahepatic cholangiocarcinoma.
Journal: Cancer letters
Published: April 24, 2025
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 08, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancer.
Journal: Clinical and translational medicine
Published: October 13, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors.
Journal: Journal of translational medicine
Published: April 14, 2024
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion.
Journal: Hepatology international
Published: August 17, 2022
SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: August 27, 2021
Endoscopic retrograde appendicitis therapy versus laparoscopic appendectomy versus open appendectomy for acute appendicitis: a pilot study.
Journal: BMC gastroenterology
Published: June 29, 2021
Integrated MicroRNA Expression Profile Reveals Dysregulated miR-20a-5p and miR-200a-3p in Liver Fibrosis.
Journal: BioMed research international
Published: April 18, 2021
FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating miR-212-3p/FOXA1/AGR2 Signaling Pathway.
Journal: OncoTargets and therapy
Published: March 07, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026